01:02:18duration 1 hour 2 minutes
10/4/17 A Selective Overview of NCCN Activities
Robert Carlson, MD NCCN Chief Executive Officer
59:35duration 59 minutes 35 seconds
Antisense Oligonuclectide Treatment of…
Antisense Oligonuclectide Treatment of Neurodegenteration
October 1, 2014 Grand Rounds
Antisense Oligonucleotide Treatment of…
Antisense Oligonucleotide Treatment of Neurodegeneration
October 1, 2014
01:06:56duration 1 hour 6 minutes
The blood pressure ruckus & geriatric…
The blood pressure ruckus & geriatric hypertension
Internal Medicine grand rounds
01:01:19duration 1 hour 1 minute
01/19/12 - EPO's Widespread Functions in…
01/19/12 - EPO's Widespread Functions in Therapy and Doping